Business description: PCAS

PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows:

- synthesized pharmaceutical products (63.5%);

- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).

At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.

France accounts for 76% of net sales.

Number of employees: 1,178

Sales by Activity: PCAS

Fiscal Period: December 2019 (EUR) 2020 (EUR) 2021 (EUR) 2022 (EUR)

Pharmaceutical Synthesis

128M 135M 120M 144M

Fine Speciality Chemicals

73.25M 58.92M 67.41M 82.72M

Geographical breakdown of sales: PCAS

Fiscal Period: December 2019 (EUR) 2020 (EUR) 2021 (EUR) 2022 (EUR)

France

163M 155M 143M 172M

Other Areas

38.01M 38.92M 44.36M 54.3M

Executive Committee: PCAS

Manager TitleAgeSince
Chief Executive Officer 43 02/05/2025
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 28/02/1999

Composition of the Board of Directors: PCAS

Director TitleAgeSince
Director/Board Member 74 28/02/2014
Director/Board Member - -

Company details: PCAS

PCAS SA

21, Chemin de la Sauvegarde

69134, Écully

+33 1 69 09 77 85

address PCAS(PCA)

Other Pharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
-2.48%-6.72%+44.19%+156.43% 1,054B
-1.52%-5.01%+61.87%+58.79% 621B
-1.30%-3.88%+27.81%+79.97% 438B
-1.12%-3.68%+26.89%+20.58% 325B
-1.73%-3.45%+26.95%+44.09% 281B
-1.95%-13.92%+15.96%+19.76% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-1.44%-3.49%+19.60%+56.20% 195B
-1.04%-4.63%+16.01%+68.47% 163B
Average -1.24%-1.70%+23.49%+51.60% 395.13B
Weighted average by Cap. -0.90%-1.69%+33.17%+77.04%